Company news
MacroGenics, Inc. news in 2023
MacroGenics, Inc.'s news releases, calls and decks from 2023, newest first.
MacroGenics Provides Update on Corporate Progress and Third Quarter 2023 Financial Results
November 5, 2023
MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call
October 30, 2023
MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
September 4, 2023
MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial Results
August 8, 2023
MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference Call
July 30, 2023
MacroGenics Provides Update on Corporate Progress and First Quarter 2023 Financial Results
May 8, 2023
MacroGenics Announces Date of First Quarter 2023 Financial Results Conference Call
May 3, 2023
MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)
March 21, 2023
MacroGenics Provides Corporate Update and 2022 Financial Results
March 14, 2023
MacroGenics Announces Sale of TZIELD™ Royalty Interest for up to $200 Million
March 7, 2023
MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call
March 6, 2023
MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium
February 12, 2023
MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 3, 2023
MacroGenics Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors
January 3, 2023